Animal models in diabetes mellitus;LE DIABETE ET SES MODELES ANIMAUX

Therapie

Volumn 52, Issue 5, 1997, Pages 375-384

  Duhault, J ^a   Koenig Berard, E ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Animal model; Diabetic complications; Insulin dependent diabetes mellitus (IDDM); Non insulin dependent diabetes mellitus (NIDDM); Transgenesis

Indexed keywords

ALLOXAN DIABETES MELLITUS; ANIMAL MODEL; AUTOIMMUNITY; CONFERENCE PAPER; COXSACKIE VIRUS; DIABETES MELLITUS; HAMSTER; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MONKEY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY; PRIORITY JOURNAL; RAT; RETROVIRUS; STREPTOZOCIN DIABETES; TRANSGENIC ANIMAL; VIRUS INFECTION; ANIMAL; ARTICLE; DISEASE MODEL; HUMAN;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; MICE; RATS;

EID: 0031216375     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Öztürk Y, Altan VM, Yildizoglu-Ari N. Effects of experimental diabetes and insulin on smooth muscle function. Pharmacol Rev 1996; 48(1): 69-112.
2. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85: 291-297.
3. Pickup JC, Williams G. Textbook of Diabetes. Oxford: Blackwell Scientific Publications, 1991.
4. Rifkin H, Porte D. Diabetes Mellitus. Theory and Practice. New York: Elsevier, 1990.
5. Shafrir, E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes & Metabolism 1996; 22: 122-131.
6. Longchampt M, Guardiola B, Sicot N et al., Protective effect of a purified flavonoid fraction against reactive oxygen radicals. Arzneim.-Forsch/Drug Res 1989; 39-II(8): 882-885.
7. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulities: new model of diabetes mellitus. Science 1976; 193: 415-417.
8. Duhault J, Buré J. T-cell dependancy of streptozotocin induced diabetes. IRCS Med Sci 1979; 7: 154.
9. Duhault J, Boulanger M, Espinal J et al. Latent auto-immune diabetes mellitus in adult humans with non-insulin-dependent diabetes: is Psammomys obesus a suitable animal model ? Acta Diabetol 1995; 32: 92-94.
10. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models. Diabetes Care 1991; 14: 195-202.
11. Chan CB. b-Cell stimulus-secretion coupling defects in rodent models of obesity. Can J Physiol Pharmacol 1995; 73: 1414-1424.
12. Pedersen O. The impact of obesity on the pathogenesis of non-insulin-dependent diabetes mellitus: a review of current hypotheses. Diabetes Metab Rev 1989; 5(6): 495-509.
13. Duhault J, Lebon F, Boulanger M. K K. Mice: a model of microangiopathic lesions in diabetes. Bibl anat 1973; 11: 453-458.
14. Baba T, Neugebauer S. The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity. Drugs 1994; 47(3): 383-404.
15. Duhault J, Lacour F, Boulanger M et al. S15261, a new compound for the treatment of the insulin resistance syndrome. Diabetologia 1994; 37: 969-975.
16. Feletou M, Moreau N, Boulanger M, Duhault J. Effect of aging and drug-induced weight reduction on rat vascular reactivity. J Cardiovasc Pharmacol 1993; 21: 120-127.
17. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
18. Hansen BC, Bodkin NL. Heterogeneity of insulin responses: phases to types II (non insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 1986; 29: 713-719.
19. Marquié G, Duhault J, Jacotot B. Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome. Diabetes 1984; 33: 438-443.
20. Patti ME, Kahn CR. Lessons from transgenic and knock out animals about noninsulin-dependent diabetes mellitus. Trends Endocrinol Metab 1996; 7: 311-319.
21. Efrat S. Role of glucokinase in regulation of insulin secretion: Lesson from transgenic mice. In: Shafrir E, ed. Lessons from Animal Diabetes VI, 1996: 123-130.
22. Katz EB, Stenbit AE, Hatton K et al. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUTA 4. Nature 1995; 377: 151-155.
23. Marban SL, Roth J. Transgenic hyperinsulinemia: A mouse model of insulin resistance and glucose intolerance without obesity. In: Shafrir E, ed. Lessons from Animal Diabetes VI, 1996: 201-204.
24. Verchere CB, d'Alessio DA, Kahn SE. Consequences of human IAPP expression in transgenic mice. In: Shafrir F., ed. Lessons from Animal Diabetes VI, 1996: 131-148.
25. Höppener JWM, Verbeek JS, de Koning EJP et al. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 1993; 36: 1258-1265.
26. Itakura M, Li S, Ohta M, Yamaoka T. Polyol accumulation versus diabetic retinopathy and nephropathy in transgenic mice expressing human aldose reductase. In: Shafrir E, ed. Lessons from Animal Diabetes VI, 1996a: 175-200.
27. Rajkumar K, Dheen ST, Murphy LJ. Hyperglycemia and impaired glucose tolerance in IGF binding protein-1 transgenic mice. Am J Physiol 1996; 270: E565-E571.
28. Itakura M, Moritani M, Yoshimoto K et al. Immunostimulatory versus immunosuppressive roles of IL-10 in IDDM: analysis with IL-10-producing transgenic NOD mice. In: Shafrir E, ed. Lessons from Animal Diabetes VI, 1996: 149-173.
29. Duhault J, Lebon F, Boulanger M, Du Boistesselin R. Diabète provoqué par la streptozotocine chez le rat: lésions rénales et rétiniennes. Biochemistry and Experimental Biology 1973; 10(4): 301-304.
30. Duhault J, Lebon F, Boulanger M et al. Microangiopathie diabétique: étude comparative chez l'homme et l'animal. Biorheology 1974; 11: 167-178.
31. Cohen AM, Rosenmann E, Rosenthal T. The Cohen diabetic (non-insulin-dependent) hypertensive rat model. Description of the model and pathologic findings. Am J Hypertens 1993; 6: 989-995.
32. Simionescu M, Popov D, Sima A et al. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster. Am J Pathol 1996; 148: 997-1014.
33. Wilson JM. Perspectives series: molecular medicine in genetically engineered animals. Animal models of human disease for gene therapy. J Clin Invest 1996; 97(5): 1138-1141.